Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus: Potential for Immunotherapy

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.5, 2001-05, pp. : 291-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in the Development of Immune-Based Therapies for Type 1 Diabetes Mellitus

By Matthias von Herrath Rottembourg Diane Bresson Damien

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 341-350

Adis International

Access to resources Recommend Favorite

Glucagon-Like Peptide 1 and Gastric Inhibitory Polypeptide: Potential Applications in Type 2 Diabetes Mellitus

By Meier J.J.

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 93-102

Adis International

Access to resources Recommend Favorite

Iliopsoas abscess in adolescents with type 1 diabetes mellitus

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 638-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Immune-Mediated Uveitis

By Smith J.R. Rosenbaum J.T.

BioDrugs, Vol. 13, Iss. 1, 2000-01 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite

Spotlight on Insulin Detemir in Type 1 and 2 Diabetes Mellitus

By Chapman Therese M. Perry Caroline M.

BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite